Our results demonstrated that BD and BD+ antagonist treatments significantly reduced Nogo‐A expression levels in peri‐infarct brain tissue compared to those in the model group, indicating the capacity of BD to attenuate Nogo‐A‐mediated inhibition and facilitate neural regeneration in rats with PSS. The gene discussed is RTN4; the disease is Behcet disease.